Using a new scan to guide biopsy for prostate cancer diagnosis
Part of Cancer, Kidney & urinary clinical trials.
This study tests a new way to guide prostate biopsies using a special scan (PSMA PET/CT) that highlights suspicious areas. If you need a biopsy because of high PSA and abnormal MRI, this approach might help make the biopsy more accurate.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You need a prostate biopsy because your PSA level is above 4 ng/mL and you have at least one suspicious spot on an MRI (PI-RADS 3 or higher).
- You have at least one suspicious spot on a PSMA PET/CT scan.
- You have never had a prostate biopsy before.
- You have not had chemotherapy, radiation to the pelvis, or hormone therapy for prostate cancer.
- You have not had any prior prostate surgery (like TURP).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a special scan called PSMA PET can help diagnose prostate cancer in men whose MRI results are not clear. It may help avoid unnecessary biopsies.
This trial tests if a special PET/MR scan can help guide a second prostate biopsy in men with rising PSA. It may reduce the need for unnecessary biopsies.
This trial uses a special PET/MR scan to help doctors aim stereotactic radiation more precisely for certain higher-risk or unfavorable intermediate prostate cancers. It studies whether this targeted approach can safely treat the prostate (and specific areas needing extra treatment) without spreading to the body.
This Phase 3 study checks whether a PSMA PET/CT scan (using a special tracer) can help doctors make better decisions for people with prostate cancer after treatment, based on PSA blood test changes. It may help identify whether cancer has spread or how to plan next steps.
This trial tests if combining a PSMA PET scan with an MRI can better detect clinically significant prostate cancer than MRI alone. It may help men who have not had a prostate biopsy before and have certain risk factors.
This study uses a special type of PET/MRI scan and targeted biopsies to find prostate cancer in men who have a high PSA density but a normal MRI or negative biopsy. It aims to better detect cancer that may be missed by standard tests.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.